Email: cspc@cspc.cn
News
July 31, 2026
Share:
Previous: VOLUNTARY ANNOUNCEMENT - PHASE IB/II CLINICAL TRIAL OF SYS 6090 INJECTION FOR THE TREATMENT OF COLORECTAL CANCER OFFICIALLY INITIATED AT THE FIRST CENTRE IN CHI
Next: VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SYH2062 INJECTION FOR THE TREATMENT OF ADULT ESSENTIAL HYPERTENSION OFFICIALLY INITIATED AT THE FIRST CENTRE
Contact Us
Phone:
+86 311 8703 7015
Email:
cspc@cspc.cn
Products
Science
About Us
